News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
144 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8525)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Drug Development
Aptinyx Granted Fast Track Designation, Initiates Phase I for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder
The U.S. Food and Drug Administration has granted Aptinyx Fast Track designation for the development of NYX-783 for the treatment of PTSD.
December 7, 2017
·
3 min read
Business
Castle Biosciences Announces the Appointment of Frank Stokes as Chief Financial Officer
He joined Castle Biosciences effective December 4, 2017.
December 7, 2017
·
2 min read
Deals
ImmunoPrecise to Acquire ModiQuest Research BV
The Transaction continues to realize on the Board’s commitment to grow globally through strategic acquisitions.
December 7, 2017
·
5 min read
Business
Hepa Wash Initiates Collaboration With German Accelerator Life Sciences to Prepare U.S. Expansion
Hepa Wash’s U.S. expansion will be guided by a team of GALS mentors with profound commercial and technical expertise in the field of organ support.
December 7, 2017
·
4 min read
Gecko Biomedical Builds Out Strategy For ‘Print On’ Polymers Platform
Gecko’s proprietary technology platform is composed of fully synthetic light-activated polymers that can be ‘printed’ on living tissue inside and outside the body.
December 7, 2017
·
4 min read
Drug Development
Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at American Society of Hematology’s Annual Meeting
The results of the study will be presented during Program Session 506: Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells.
December 7, 2017
·
5 min read
SuperSonic Imagine Installs Six Aixplorer Ultimate Ultrasound Systems at ‘Occitanie-Garonne’ Medical Imaging Group
The radiology sites specialize, among other things, in detecting and characterising musculotendinous and mammary lesions, and diagnosing abdominal diseases with 14 radiologists who conduct all of the diagnostic and therapeutic exams.
December 7, 2017
·
5 min read
Drug Development
Novo Nordisk’s Tresiba Reduces Hypoglycaemia Regardless of Blood Sugar Level
These new post-hoc analyses from the SWITCH 1 and 2 trials were presented at the International Diabetes Federation Annual Congress in Abu Dhabi today.
December 7, 2017
·
5 min read
Drug Development
Long-Term Efficacy Data From the Phase III GeparSepto Study in High Risk Early Breast Cancer Patients Treated With ABRAXANE Vs. Solvent-Based Paclitaxel to Be Reported
The results from the 1,206 patient study found that ABRAXANE demonstrated a significantly higher disease-free survival rate, a secondary efficacy endpoint, in high risk early breast cancer patients when compared to conventional solvent-based paclitaxel.
December 7, 2017
·
14 min read
EOS Imaging Awarded ihe Prix Galien in ihe Medical Device Category
EOS Imaging today announced the Galien Foundation has awarded it the Prix Galien in the Medical Device category.
December 7, 2017
·
2 min read
Previous
9 of 15
Next